Shira Grock1, Jeong-Hee Ku2, Julie Kim2, Tannaz Moin3. 1. Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, David Geffen School of Medicine at UCLA, 900 Veteran Avenue, 24-130 Warren Hall, Los Angeles, CA, 90095, USA. sgrock@mednet.ucla.edu. 2. Division of Endocrinology, Diabetes and Hypertension, Department of Medicine, David Geffen School of Medicine at UCLA, 900 Veteran Avenue, 24-130 Warren Hall, Los Angeles, CA, 90095, USA. 3. Veterans Affairs Greater Los Angeles Healthcare Systems, 10940 Wilshire Boulevard, Suite 700, Los Angeles, CA, 90024, USA.
Abstract
PURPOSE OF REVIEW: The high prevalence of prediabetes and success of the diabetes prevention program (DPP) has led to increasing efforts to provide readily accessible, cost-effective DPP interventions to the general public. Technology-assisted DPP interventions are of particular interest since they may be easier to widely distribute and sustain as compared to traditional in-person DPP. The purpose of this article is to provide an overview of currently available technology-assisted DPP interventions. RECENT FINDINGS: This review focuses on studies that have examined the use of mobile phone text messaging, smartphone/web-based apps, and telehealth programs to help prevent or delay the onset of incident type 2 diabetes. While there is variability in the results of studies focused on technology-assisted DPP and weight loss interventions, there is evidence to suggest that these programs have been associated with clinically meaningful weight loss and can be cost-effective. Patients who are at risk for diabetes can be offered technology-assisted DPP and weight loss interventions to lower their risk of incident diabetes. Further research should determine what specific combination of intervention features would be most successful.
PURPOSE OF REVIEW: The high prevalence of prediabetes and success of the diabetes prevention program (DPP) has led to increasing efforts to provide readily accessible, cost-effective DPP interventions to the general public. Technology-assisted DPP interventions are of particular interest since they may be easier to widely distribute and sustain as compared to traditional in-personDPP. The purpose of this article is to provide an overview of currently available technology-assisted DPP interventions. RECENT FINDINGS: This review focuses on studies that have examined the use of mobile phone text messaging, smartphone/web-based apps, and telehealth programs to help prevent or delay the onset of incident type 2 diabetes. While there is variability in the results of studies focused on technology-assisted DPP and weight loss interventions, there is evidence to suggest that these programs have been associated with clinically meaningful weight loss and can be cost-effective. Patients who are at risk for diabetes can be offered technology-assisted DPP and weight loss interventions to lower their risk of incident diabetes. Further research should determine what specific combination of intervention features would be most successful.
Entities:
Keywords:
Diabetes prevention; Digital health; Mobile; Technology; Weight loss
Authors: Henry H Fischer; Ilana P Fischer; Rocio I Pereira; Anna L Furniss; Jeanne M Rozwadowski; Susan L Moore; Michael J Durfee; Silvia G Raghunath; Adam G Tsai; Edward P Havranek Journal: Diabetes Care Date: 2016-02-09 Impact factor: 19.112
Authors: X R Pan; G W Li; Y H Hu; J X Wang; W Y Yang; Z X An; Z X Hu; J Lin; J Z Xiao; H B Cao; P A Liu; X G Jiang; Y Y Jiang; J P Wang; H Zheng; H Zhang; P H Bennett; B V Howard Journal: Diabetes Care Date: 1997-04 Impact factor: 19.112
Authors: Thomas Rutledge; Jane A Skoyen; Julie A Wiese; Kathleen M Ober; Gina N Woods Journal: Obes Res Clin Pract Date: 2016-12-05 Impact factor: 2.288
Authors: Jaana Lindström; Pirjo Ilanne-Parikka; Markku Peltonen; Sirkka Aunola; Johan G Eriksson; Katri Hemiö; Helena Hämäläinen; Pirjo Härkönen; Sirkka Keinänen-Kiukaanniemi; Mauri Laakso; Anne Louheranta; Marjo Mannelin; Merja Paturi; Jouko Sundvall; Timo T Valle; Matti Uusitupa; Jaakko Tuomilehto Journal: Lancet Date: 2006-11-11 Impact factor: 79.321
Authors: Dean J Wantland; Carmen J Portillo; William L Holzemer; Rob Slaughter; Eva M McGhee Journal: J Med Internet Res Date: 2004-11-10 Impact factor: 5.428